REGN Snapshot
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors.
Market Capitalization$88,846,279,000
Price to Sales6.76
Earnings per Share$35.0800
PE Ratio23.25
Most Recent Close$820.9000
52 Week High$853.97
52 Week Low$668
50-Day Moving Average$813.09
200-Day Moving Average$784.84
All data are from Alpha Vantage as of today. For more infomation on REGN see Stock Dividend, Valuation, Price and Financial Data for Investors